Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions

Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions

US Patent 6300346 · Granted Oct 9, 2001

Estimated economic value: $3,168,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of therapeutically treating cancer2025
Derivatives of sulindac can protect normal cells against oxidative damage2023
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2022
Composition comprising red cell-derived microparticles and method of treating ex2022
Method of treating or preventing Ras-mediated diseases2021
Derivatives of sulindac can protect normal cells against oxidative damage2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Method of treating or preventing Ras-mediated diseases2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2021
Indenyl compounds, pharmaceutical compositions, and medical uses thereof2020
Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use2019